• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Gilead-backed cell therapy startup Kyverna adds fresh funds for new strategy

cafead

Administrator
Staff member
  • cafead   Aug 03, 2023 at 10:22: AM
via A treatment licensed from the NIH and in clinical testing for lupus is the startup’s lead program, while its founding “Treg” cell therapy research matures, according to CEO Peter Maag.

article source
 

<